tiprankstipranks
Trending News
More News >
Bio-Rad Laboratories (BIO)
NYSE:BIO
US Market
Advertisement

Bio-Rad Laboratories (BIO) Financial Statements

Compare
905 Followers

Bio-Rad Laboratories Financial Overview

Bio-Rad Laboratories's market cap is currently $7.21B. The company's EPS TTM is $2.61; its P/E ratio is 22.53; Bio-Rad Laboratories is scheduled to report earnings on July 31, 2025, and the estimated EPS forecast is $1.97. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 2.57B$ 2.67B$ 2.80B$ 2.92B$ 2.55B
Gross Profit$ 1.38B$ 1.43B$ 1.57B$ 1.64B$ 1.44B
Operating Income$ 269.00M$ 337.80M$ 482.62M$ 500.34M$ 421.33M
EBITDA$ -2.14B$ -654.80M$ -4.49B$ 5.59B$ 5.08B
Net Income$ -1.84B$ -637.32M$ -3.63B$ 4.25B$ 3.81B
Balance Sheet
Cash & Short-Term Investments$ 1.66B$ 1.61B$ 1.79B$ 869.92M$ 991.12M
Total Assets$ 9.36B$ 12.30B$ 13.50B$ 17.80B$ 12.97B
Total Debt$ 1.37B$ 1.41B$ 1.39B$ 223.38M$ 225.74M
Net Debt$ 886.60M$ 1.00B$ 953.88M$ -247.41M$ -436.47M
Total Liabilities$ 2.79B$ 3.56B$ 3.89B$ 4.11B$ 3.09B
Stockholders' Equity$ 6.57B$ 8.74B$ 9.62B$ 13.69B$ 9.88B
Cash Flow
Free Cash Flow$ 266.20M$ 218.26M$ 80.29M$ 535.72M$ 476.41M
Operating Cash Flow$ 455.20M$ 374.94M$ 194.45M$ 669.46M$ 584.97M
Investing Cash Flow$ -160.20M$ 20.21M$ -1.21B$ -797.38M$ -69.89M
Financing Cash Flow$ -218.80M$ -425.65M$ 973.58M$ -55.43M$ -523.04M
Currency in USD

Bio-Rad Laboratories Earnings and Revenue History

Bio-Rad Laboratories Debt to Assets

Bio-Rad Laboratories Cash Flow

Bio-Rad Laboratories Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis